STAT+: FDA appears open to Moderna’s flu vaccine ahead of adcomm

▤ Summary

The article focuses on Moderna’s flu vaccine and the FDA’s apparent willingness to move it forward before an advisory committee meeting. It also mentions related biotech developments, including UniQure’s Huntington’s therapy and Eli Lilly’s acquisition activity. The main news is regulatory in nature and centers on a vaccine candidate in the pharma sector. This creates a signal for companies that support clinical development, regulatory workflows, or life sciences commercialization. The piece is relevant to readers tracking biotech and pharma industry momentum, but it is not a software-company event.

▦ Linked Companies